Finance

Lists
Why is 300181 up 4.64%?
Dive Deeper
300181:SHE
Zhejiang Jolly Pharmaceutical Co Ltd
CN¥12.85
+4.64%
(+0.57) 1D
Nov 17, 3:04:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300181...
Open
CN¥12.23
High
CN¥12.93
Low
CN¥12.21
Mkt. cap
8.61B
Avg. vol.
9.31M
Volume
26.54M
Dividend
4.09%
Quarterly dividend
CN¥0.13
Ex-dividend date
Sep 23, 2026
P/E ratio
14.13
52-wk high
CN¥18.65
52-wk low
CN¥11.84
EPS
CN¥0.91
Shares outstanding
701.39M
No. of employees
3K
Open
CN¥12.23
High
CN¥12.93
Low
CN¥12.21
Mkt. cap
8.61B
Avg. vol.
9.31M
Volume
26.54M
Dividend
4.09%
Quarterly dividend
CN¥0.13
Ex-dividend date
Sep 23, 2026
P/E ratio
14.13
52-wk high
CN¥18.65
52-wk low
CN¥11.84
EPS
CN¥0.91
Shares outstanding
701.39M
No. of employees
3K
News stories
From web sources and news partners
About Zhejiang Jolly Pharmaceutical Co Ltd
CEO-
Employees2.86K
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitezuoli.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
761.05M
897.80M
866.34M
745.83M
Cost of goods sold
312.62M
324.69M
339.56M
304.29M
Cost of revenue
312.62M
324.69M
339.56M
304.29M
Research and development expenses
27.59M
10.62M
12.03M
16.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
306.06M
329.11M
314.16M
281.68M
Operating expense
327.68M
328.51M
318.51M
278.72M
Total operating expenses
640.30M
653.20M
658.07M
583.01M
Operating income
120.75M
244.60M
208.28M
162.82M
Other non operating income
6.88M
-37.17K
-28.28K
-61.72K
EBT including unusual items
144.91M
237.61M
209.06M
141.01M
EBT excluding unusual items
124.44M
241.07M
204.33M
158.58M
Income tax expense
20.58M
35.60M
31.81M
19.65M
Effective tax rate
14.20%
14.98%
15.22%
13.93%
Other operating expenses
-2.37M
-17.70M
-7.60M
-22.33M
Net income
121.96M
199.59M
175.34M
119.74M
Net profit margin
16.03%
22.23%
20.24%
16.05%
Earnings per share
-
-
-
-
Interest and investment income
633.16K
640.44K
560.35K
448.43K
Interest expense
-3.82M
-4.13M
-4.48M
-4.63M
Net interest expenses
-3.19M
-3.49M
-3.92M
-4.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
139.48M
263.33M
234.34M
181.55M
Gain or loss from assets sale
-591.24K
-
195.05K
-195.05K
Upcoming events
AI content may include mistakes. Learn more
Google apps